Yersinia enterocolitica serotype 0:3-induced arthritis in mice: microbiological and histopathological information.
Gross anatomical and histopathological changes in arthritic joints resulting from oral challenge with Yersinia enterocolitica serotype 0:3, upon pretreatment with desferrioxamine, were always more severe than those induced by intravenous infection of immunized animals. In all the acute inflammation episodes studied, live Yersiniae were isolated from the arthritic region. Invariably, a heavy mixed infiltration of synovia, joint spaces and soft tissues was observed at this stage. Concurrent fibrous thickening and vascular proliferation, along with erosion of articular cartilages and anomalous bone regeneration, were also apparent. In spite of these significant facts, the bacterium could be histopathologically identified only in bone marrow where it developed microcolonies and caused significant necrosis as well. The live bacterium was also retrieved from two- and six-month-old arthritic ankles/paws examined, but it could not be seen in histological sections of joints. By this time, no cellular infiltration was evident, but there was extensive fibrosis. Bones were at times greatly enlarged, showing a spongeous-like structure. Additionally, articular cartilages could be completely lost and were substituted by an anomalous ossification filling the joint spaces. This situation led to bone fusion, resembling articular ankylosing traits. In summary, we present the first experimental evidence that Y. enterocolitica serotype 0:3 is a causal agent of osteoarthritis and osteomyelitis, and that it may survive for prolonged periods of time in osseous structures.
de los Toyos
J R
JR
Area de Microbiología, Facultad de Medicina, Universidad de Oviedo, Spain.
Menéndez
P
P
Sampedro
A
A
Hardisson
C
C
D000818:Animals; D001170:Arthritis, Infectious / Q000382:microbiology* / Q000473:pathology*; D001853:Bone Marrow / Q000382:microbiology / Q000473:pathology; D002358:Cartilage, Articular / Q000382:microbiology / Q000473:pathology; D003676:Deferoxamine / Q000494:pharmacology; D004195:Disease Models, Animal; D005260:Female; D007596:Joints / Q000382:microbiology* / Q000473:pathology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D012703:Serotyping; D015009:Yersinia Infections; D015008:Yersinia enterocolitica / Q000145:classification / Q000302:isolation & purification*
D003676:Deferoxamine